[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Competitor Analysis: Adenosine Receptor Agonists & Antagonists

April 2011 | 26 pages | ID: C0FE69CFF4FEN
La Merie Publishing

US$ 287.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The present Competitive Intelligence Report about Adenosine Receptor Agonists & Antagonists provides a competitor evaluation in the field of novel molecules being developed for treatment of a variety of diseases as of April 2011. Depending on the adenosine receptor subtype (A1, A2, A3) and on stimulation or blockade, molecules find use for treatment of diseases including glaucoma, dry eye, cardiac imaging, asthma, psoriasis, rheumatoid arthritis as well as Parkinson’s diasese. Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and any updates since the publication date. Credentials to access the database will be sent by e-mail and allow online work with the project data to print or export an individual report.

The report includes a compilation of currently active projects in research and development of novel adenosine receptor agonists & antagonists. In addition, the report lists company-specific R&D pipelines of adenosine receptor agonists & antagonists in R&D. Competitor projects are listed in a tabular format providing information on:
  • Drug Codes,
  • Target / Mechanism of Action,
  • Class of Compound,
  • Company,
  • Product Category,
  • Indication,
  • R&D Stage and
  • additional comments with a hyperlink leading to the source of information.

Index
  • Adenosine A1 Receptor Agonists
  • Adenosine A2 Receptor Agonists
  • Adenosine A3 Receptor Agonists
  • Adenosine A1 Receptor Antagonists
  • Adenosine A2 Receptor Antagonists
  • Adenosine A3 Receptor Antagonists
  • Other Adenosine Receptor Antagonists
  • Adenosine Related Agents
  • Corporate Targeted Therapy of Obesity R&D Pipelines
  • About Competitor Analysis Series:

The Competitor Analysis Series delivers NO-FRILLS, but concise information about the pipeline of R&D projects for targets, diseases, technologies and companies at low prices. The information is provided in a tabular format and fully referenced.


More Publications